Establishment of pluripotent cell lines from vertebrate species - Present status and future prospects

Pluripotent embryonic stem (ES) cells are undifferentiated cell lines derived from early embryos and are capable of unlimited undifferentiated proliferation in vitro. They retain the ability to differentiate into all cell types including germ cells in chimeric animals in vivo, and can be induced to form derivatives of all three germ layers in vitro. Mouse ES cells represent one of the most important tools in genetic research. Major applications include the targeted mutation of specific genes by homologous recombination and the discovery of new genes by gene trap strategies. These applications would be of high interest for other model organisms and also for livestock species, However, in spite of tremendous research activities, no proven ES cells colonizing the germ line have been established for vertebrate species other than mouse a nd chicken thus far. This review summarizes the current status of deriving pluripotent embryonic stem cell lines from vertebrates and recent developments in nuclear transfer technology, which may provide an alternative tool for genetic modification of livestock animals. Copyright (C) 1999 S. Karger AG, Basel

Mouse embryonic stem cells: The establishment of the system to produce differentiated cell types in vitro

During the last few years, embryonic stem (ES) cells have been a new tool in cell biology which is very promising for the scientific community to develop new cell therapies. ES cells are the only cell type that can differentiate into derivates of the three primary germ layers, not only in vivo but also, and most important, in vitro. This so-called pluripotency has resulted in the field of stem cell technology going into overdrive, and the establishment of many protocols for optimal maintenance, culture, genetic transfection and in vitro differentiation. The first pluripotent cells had been derived from teratocarcinomas, maligne tumors, and showed some disadvantages. Therefore later embryonic stem cells, and now adult stem cells are getting special attention from the scientists. In this study, we established for the first time in our country, the prolonged culture of undifferentiated ES cells in vitro and the pointed induction of cell differentiation into specific cell types. It is the result of an international collaboration program supported by Brazil and Germany, CAPES and DAAD (PROBRAL). The well-established routine should be clearly demonstrated by the continuous culture and propagation of several mouse ES lines in vitro under specific culture conditions preventing differentiation. On the other hand, these ES cells were exposed to defined differentiation induction systems to obtain specialized cells as cardiogenic, neurogenic and myogenic cell types. This demonstrates the successful procedure to induce ES cell line differentiation. In this study, we established both routine systems, with and without differentiation. This results gave us competence and possibility to develop a series of different scientific approaches

Mouse embryonic stem cells: the establishment of the system to produce differentiated cell types in vitro

During the last few years, embryonic stem (ES) cells have been a new tool in cell biology which is very promising for the scientific community to develop new cell therapies. ES cells are the only cell type that can differentiate into derivates of the three primary germ layers, not only in vivo but also, and most important, in vitro. This so-called pluripotency has resulted in the field of stem cell technology going into overdrive, and the establishment of many protocols for optimal maintenance, culture, genetic transfection and in vitro differentiation. The first pluripotent cells had been derived from teratocarcinomas, maligne tumors, and showed some disadvantages. Therefore later embryonic stem cells, and now adult stem cells are getting special attention from the scientists. In this study, we established for the first time in our country, the prolonged culture of undifferentiated ES cells in vitro and the pointed induction of cell differentiation into specific cell types. It is the result of an international collaboration program supported by Brazil and Germany, CAPES and DAAD (PROBRAL). The well-established routine should be clearly demonstrated by the continuous culture and propagation of several mouse ES lines in vitro under specific culture conditions preventing differentiation. On the other hand, these ES cells were exposed to defined differentiation induction systems to obtain specialized cells as cardiogenic, neurogenic and myogenic cell types. This demonstrates the successful procedure to induce ES cell line differentiation. In this study, we established both routine systems, with and without differentiation. This results gave us competence and possibility to develop a series of different scientific approaches

Growth hormone (GH)/GH receptor expression and GH-mediated effects during early bovine embryogenesis

Pituitary growth hormone (GH) stimulates postnatal growth and metabolism. The role of CH and its receptor (GHR) during prenatal development, however, is still controversial. As shown by reverse transcription polymerase chain reaction (RT-PCR), bovine in vitro fertilization embryos synthesized the transcript of GHR from Day 2 of embryonic life onwards. Real time RT-PCR revealed that synthesis of GHR mRNA was increased 5.9-fold in 6-day-old embryos compared with 2-day-old embryos. Using in situ hybridization, the mRNA encoding GHR was predominantly localized to the inner cell mass of blastocysts. The GHR protein was first visualized 3 days after fertilization. GH-specific transcripts were first detected in embryos on Day 8 of in vitro culture. As shown by transmission electron microscopy, GH treatment resulted in elimination of glycogen storage in 6- to 8-day-old embryos and an increase in exocytosis of lipid vesicles. These results suggest that a functional GHR able to modulate carbohydrate and lipid metabolism is synthesized during preimplantation development of the bovine embryo and that this GHR may be subject to activation by embryonic GH after Day 8

A dynamic model of circadian rhythms in rodent tail skin temperature for comparison of drug effects

<p>Abstract</p> <p>Menopause-associated thermoregulatory dysfunction can lead to symptoms such as hot flushes severely impairing quality of life of affected women. Treatment effects are often assessed by the ovariectomized rat model providing time series of tail skin temperature measurements in which circadian rhythms are a fundamental ingredient. In this work, a new statistical strategy is presented for analyzing such stochastic-dynamic data with the aim of detecting successful drugs in hot flush treatment. The circadian component is represented by a nonlinear dynamical system which is defined by the van der Pol equation and provides well-interpretable model parameters. Results regarding the statistical evaluation of these parameters are presented.</p

Effects of estrogen, an ERα agonist and raloxifene on pressure overload induced cardiac hypertrophy.

The aim of this study was to investigate the effects of 17β-estradiol (E2), the selective ERα agonist 16α-LE2, and the selective estrogen receptor modulator (SERM) raloxifene on remodeling processes during the development of myocardial hypertrophy (MH) in a mouse model of pressure overload. Myocardial hypertrophy in ovariectomized female C57Bl/6J mice was induced by transverse aortic constriction (TAC). Two weeks after TAC, placebo treated mice developed left ventricular hypertrophy and mild systolic dysfunction. Estrogen treatment, but not 16α-LE2 or raloxifene reduced TAC induced MH compared to placebo. E2, 16α-LE2 and raloxifene supported maintenance of cardiac function in comparison with placebo. Nine weeks after induction of pressure overload, MH was present in all TAC groups, most pronounced in the raloxifene treated group. Ejection fraction (EF) was decreased in all animals. However, 16α-LE2 treated animals showed a smaller reduction of EF than animals treated with placebo. E2 and 16α-LE2, but not raloxifene diminished the development of fibrosis and reduced the TGFβ and CTGF gene expression. Treatment with E2 or 16α-LE2 but not with raloxifene reduced survival rate after TAC significantly in comparison with placebo treatment. In conclusion, E2 and 16α-LE2 slowed down the progression of MH and reduced systolic dysfunction after nine weeks of pressure overload. Raloxifene did not reduce MH but improved cardiac function two weeks after TAC. However, raloxifene was not able to maintain EF in the long term period

Mouse embryonic stem cells: the establishment of the system to produce differentiated cell types in vitro

During the last few years, embryonic stem (ES) cells have been a new tool in cell biology which is very promising for the scientific community to develop new cell therapies. ES cells are the only cell type that can differentiate into derivates of the three primary germ layers, not only in vivo but also, and most important, in vitro. This so-called pluripotency has resulted in the field of stem cell technology going into overdrive, and the establishment of many protocols for optimal maintenance, culture, genetic transfection and in vitro differentiation. The first pluripotent cells had been derived from teratocarcinomas, maligne tumors, and showed some disadvantages. Therefore later embryonic stem cells, and now adult stem cells are getting special attention from the scientists. In this study, we established for the first time in our country, the prolonged culture of undifferentiated ES cells in vitro and the pointed induction of cell differentiation into specific cell types. It is the result of an international collaboration program supported by Brazil and Germany, CAPES and DAAD (PROBRAL). The well-established routine should be clearly demonstrated by the continuous culture and propagation of several mouse ES lines in vitro under specific culture conditions preventing differentiation. On the other hand, these ES cells were exposed to defined differentiation induction systems to obtain specialized cells as cardiogenic, neurogenic and myogenic cell types. This demonstrates the successful procedure to induce ES cell line differentiation. In this study, we established both routine systems, with and without differentiation. This results gave us competence and possibility to develop a series of different scientific approaches

Development of cardiac hypertrophy and LV function two weeks (grey bars) and nine weeks (black bars) after TAC.

<p>(A) Left ventricular mass to tibia length ratio (LVM/TL) was significantly reduced by E2 treatment compared to placebo or raloxifene treated animals two weeks after TAC. After nine weeks, raloxifene treated animals showed a significant higher LVM/TL than E2 treated mice. ANOVA post-hoc Scheffé; p-value p<0.05. (B) Ejection fraction (EF) showed a significant reduction of left ventricular function two weeks after TAC in placebo treated mice compared to all treated groups. Nine weeks after TAC surgery exclusively mice with ERα agonist treatment showed a significant higher EF. ANOVA post-hoc Scheffé; p-value p<0.05. (C) Factor analysis underlined the positive influence E2 and 16α-LE2 treatment on the progression of MH and loss of LV function. Broken line: factor <i>LV function</i>; solid line: <i>LV morphology</i>; Friedman test; p-value p<0.05.</p

Chronic pressure overload induced mortality.

<p>Highest survival rate was observed in placebo treated animals after TAC (92.3%; 1 out of 13). Treatment with E2 or 16α-LE2 led to a significant lower survival rate compared to placebo groups (both groups: 58.3%; 5 out of 13). Log rank Test; p<0.05.</p